Dose Reduction of IL17 and IL23 Inhibitors in Psoriasis
Clinical trial NCT04340076 · COMPLETED
Trial details
- NCT number
- NCT04340076
- Sponsor
- Radboud University Medical Center
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-20
- Primary completion
- 2025-01-30
- Enrollment
- 244
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.